Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

ARUK Consortium, Sims, Rebecca, GERAD/PERADES, CHARGE, ADGC, EADI, van der Lee, Sven J, Naj, Adam C, Bellenguez, Céline, Badarinarayan, Nandini, Jakobsdottir, Johanna +443 more·2017·Nature Genetics

Cited by (1,043)

Items 401–500 of 1,043

  1. Genetic and polygenic risk score analysis for Alzheimer's disease in the Chinese population
    Xiaopu Zhou, Yu Chen, Fanny C.F. Ip, Nicole Chit Hang Lai, Yolanda Y. T. Li, Yuanbing Jiang, Huan Zhong, Yuewen Chen, Yulin Zhang, Shuangshuang Ma et al. · 2020 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  2. Caspases orchestrate microglia instrumental functions
    Xianli Shen, Jose Luis Venero, Bertrand Joseph, Miguel Ángel Burguillos · 2018 · Progress in Neurobiology
  3. A short perspective on the long road to effective treatments for Alzheimer's disease
    David S. Reynolds · 2019 · British Journal of Pharmacology
  4. Association of mitochondrial variants and haplogroups identified by whole exome sequencing with Alzheimer's disease
    Xiaoling Zhang, John J. Farrell, Tong Tong, Junming Hu, Congcong Zhu, Alzheimer's Disease Sequencing Project, Li‐San Wang, Richard P Mayeux, Jonathan L. Haines, Margaret Ann Pericak‐Vance et al. · 2021 · Alzheimer s & Dementia
  5. Common variants in Alzheimer’s disease: Novel association of six genetic variants with AD and risk stratification by polygenic risk scores
    de Rojas, Itziar, Moreno-Grau, Sonia, Tesi, Niccolò, Grenier-Boley, Benjamin, Andrade, Victor, Jansen, Iris, Pedersen, Nancy L., Stringa, Najada, Zettergren, Anna, Hernández, Isabel et al. · 2019
  6. Tensor decomposition of stimulated monocyte and macrophage gene expression profiles identifies neurodegenerative disease-specific trans-eQTLs
    Satesh Ramdhani, Elisa Navarro, Evan Udine, Anastasia G. Efthymiou, Brian M. Schilder, Madison Parks, Alison Goate, Towfique Raj · 2020 · PLoS Genetics
  7. Neurodegenerative diseases have genetic hallmarks of autoinflammatory disease
    Robert I. Richards, Sarah Anne Robertson, Daniel L. Kastner · 2018 · Human Molecular Genetics
  8. New insights on the disease contribution of neuroinflammation in amyotrophic lateral sclerosis
    Aude Chiot, Christian S. Lobsiger, Séverine Boillée · 2019 · Current Opinion in Neurology
  9. Alzheimer’s Disease Variant Portal: A Catalog of Genetic Findings for Alzheimer’s Disease
    Pavel P. Kuksa, Chia‐Lun Liu, Wei Fu, Liming Qu, Yi Zhao, Živadin Katanić, Kaylyn Clark, Amanda B Kuzma, Pei‐Chuan Ho, Kai‐Teh Tzeng et al. · 2022 · Journal of Alzheimer s Disease
  10. Genetic Insights into the Impact of Complement in Alzheimer’s Disease
    Megan Torvell, Sarah M. Carpanini, Nikoleta Daskoulidou, Robert A.J. Byrne, Rebecca Sims, B. Paul Morgan · 2021 · Genes
  11. Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementia
    Llibre-Guerra, Jorge J., Fernandez, M. Victoria, Joseph-Mathurin, Nelly, Bian, Shijia, Carter, Kathleen, Li, Yan, Aschenbrenner, Andrew J., Pottier, Cyril, Sigurdson, Wendy, McDade, Eric et al. · 2025 · Nature Medicine
  12. Risk of dementia in <i>APOE</i> ε4 carriers is mitigated by a polygenic risk score
    Ebenau, Jarith L., van der Lee, Sven J., Hulsman, Marc, Tesi, Niccolò, Jansen, Iris E., Verberk, Inge M.W., van Leeuwenstijn, Mardou, Teunissen, Charlotte E., Barkhof, Frederik, Prins, Niels D. et al. · 2021 · Alzheimer's &amp; Dementia: Diagnosis, Assessment &amp; Disease Monitoring
  13. The involvement of microglia in Alzheimer's disease: a new dog in the fight
    Moore, Zachery, Taylor, Juliet M, Crack, Peter J · 2019 · British Journal of Pharmacology
  14. Orchestration of synaptic functions by WAVE regulatory complex‐mediated actin reorganization
    Han, Kyung Ah, Ko, Jaewon · 2023 · Experimental &amp; Molecular Medicine
  15. Multi‐Omics‐Based Autophagy‐Related Untypical Subtypes in Patients with Cerebral Amyloid Pathology
    Jong‐Chan Park, Natalia Barahona‐Torres, So‐Yeong Jang, Kin Ying Mok, Haeng Jun Kim, Sun‐Ho Han, Kwang‐Hyun Cho, Xiaopu Zhou, Amy K.Y. Fu, Nancy Y. Ip et al. · 2022 · Advanced Science
  16. Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90
    Laura M. Heath, John C. Earls, Andrew T. Magis, Sergey A. Kornilov, Jennifer C. Lovejoy, Cory C. Funk, Noa Rappaport, Benjamin A. Logsdon, Lara M. Mangravite, Brian W. Kunkle et al. · 2022 · Scientific Reports
  17. Weakly activated core neuroinflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer’s disease
    Fuhai Li, Abdallah M. Eteleeb, William Buchser, Christopher Sohn, Guoqiao Wang, Chengjie Xiong, Philip Payne, Eric McDade, Celeste M M. Karch, Oscar Harari et al. · 2022 · Frontiers in Aging Neuroscience
  18. Immunity and amyloid beta, total tau and neurofilament light chain: Findings from a community‐based cohort study
    Lana Fani, Shahzad Ahmad, M. Kamran Ikram, Mohsen Ghanbari, M. Arfan Ikram · 2020 · Alzheimer s & Dementia
  19. Genes, pathways and risk prediction in Alzheimer’s disease
    Hardy, John, Escott-Price, Valentina · 2019 · Human Molecular Genetics
  20. A single-cell compendium of human cerebrospinal fluid identifies disease-associated immune cell populations
    Claudia Cantoni, Roman A. Smirnov, Maria M. Firulyova, Prabhakar Sairam Andhey, Tara R. Bradstreet, Ekaterina Esaulova, Marina Terekhova, Elizabeth A. Schwarzkopf, Nada M. Abdalla, Maksim Kleverov et al. · 2025 · Journal of Clinical Investigation
  21. Targeting PKC in microglia to promote remyelination and repair in the CNS
    Paul M. Kim, Michael D. Kornberg · 2021 · Current Opinion in Pharmacology
  22. PD-1 deficiency is not sufficient to induce myeloid mobilization to the brain or alter the inflammatory profile during chronic neurodegeneration
    Juliane Obst, Renzo Mancuso, E. Simon, Diego Gómez‐Nicola · 2018 · Brain Behavior and Immunity
  23. Phospholipase Cγ2 regulates endocannabinoid and eicosanoid networks in innate immune cells
    Jing, Hui, Reed, Alex, Ulanovskaya, Olesya A., Grigoleit, Jan-Sebastian, Herbst, Dylan M., Henry, Cassandra L., Li, Haoxin, Barbas, Sabrina, Germain, Jason, Masuda, Kim et al. · 2021 · Proceedings of the National Academy of Sciences
  24. GWAS on family history of Alzheimer’s disease
    2018
  25. The Impact of Apolipoprotein E (APOE) Epigenetics on Aging and Sporadic Alzheimer’s Disease
    Madia Lozupone, Vittorio Dibello, Rodolfo Sardone, Fabio Castellana, Roberta Zupo, Luisa Lampignano, Ilaria Bortone, Antonio Daniele, Antonello Bellomo, Vincenzo Solfrizzi et al. · 2023 · Biology
  26. The expanding pathways of autoinflammation: a lesson from the first 100 genes related to autoinflammatory manifestations
    Riccardo Papa, Paolo P Picco, Marco Gattorno · 2019 · Advances in protein chemistry and structural biology
  27. Integration of Alzheimer’s disease genetics and myeloid genomics reveals novel disease risk mechanisms
    Novikova, Gloriia, Kapoor, Manav, TCW, Julia, Abud, Edsel M., Efthymiou, Anastasia G., Cheng, Haoxiang, Fullard, John F., Bendl, Jaroslav, Roussos, Panos, Poon, Wayne W. et al. · 2019
  28. Deep Profiling of the Aggregated Proteome in Alzheimer’s Disease: From Pathology to Disease Mechanisms
    Lutz, Brianna M., Peng, Junmin · 2018 · Proteomes
  29. Molecular biology of autoinflammatory diseases
    Junya Masumoto, Wei Zhou, Shinnosuke Morikawa, Sho Hosokawa, Haruka Taguchi, Toshihiro Yamamoto, Mie Kurata, Naoe Kaneko · 2021 · Inflammation and Regeneration
  30. Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology
    Wenhui Qiao, Yixing Chen, Jun Zhong, Benjamin J. Madden, Cristine M. Charlesworth, Yuka A. Martens, Chia‐Chen Liu, Joshua A. Knight, Tadafumi C. Ikezu, Aishe Kurti et al. · 2023 · Molecular Neurodegeneration
  31. Modern approaches to investigating non‐neuronal aspects of Alzheimer's disease
    Shane Antony Liddelow · 2019 · The FASEB Journal
  32. A Brief Synopsis on the Genetics of Alzheimer’s Disease
    Kamboh, M. Ilyas · 2018 · Current Genetic Medicine Reports
  33. Protective Variants in Alzheimer’s Disease
    Shea J. Andrews, Brian Fulton‐Howard, Alison Goate · 2019 · Current Genetic Medicine Reports
  34. Artificial Intelligence and the detection of pediatric concussion using epigenomic analysis
    Ray O Bahado-Singh, Sangeetha Vishweswaraiah, Anıl Er, Buket Aydas, Onur Türkoğlu, Birce Dilge Taşkın, Murat Duman, Durgül Yılmaz, Uppala Radhakrishna · 2019 · Brain Research
  35. One for all and all for One: Improving replication of genetic studies through network diffusion
    Daniel Lancour, Adam Christian Naj, Richard P Mayeux, Jonathan L. Haines, Margaret Ann Pericak‐Vance, Gerard D. Schellenberg, Mark E. Crovella, Lindsay A. Farrer, Simon Kasif · 2018 · PLoS Genetics
  36. Microglia – mediated immunity partly contributes to the genetic association between Alzheimer’s disease and hippocampal volume
    Thomas Matthew Lancaster, Matthew Hill, Rebecca Sims, Julie H. Williams · 2019 · Brain Behavior and Immunity
  37. Effective Knockdown of Gene Expression in Primary Microglia With siRNA and Magnetic Nanoparticles Without Cell Death or Inflammation
    Alejandro Carrillo-Jiménez, Mar Puigdellívol, Anna Vilalta, Jose Luis Venero, Guy Charles Brown, Peter St George‐Hyslop, Miguel Ángel Burguillos · 2018 · Frontiers in Cellular Neuroscience
  38. Neural Metabolic Networks: Key Elements of Healthy Brain Function
    Nimrod Madrer, Nirma D. Perera, Nonthué Alejandra Uccelli, Alice Abbondanza, Jens Velde Andersen, Emma Veronica Carsana, Matthew D. Demmings, Regina F. Fernandez, Matheus Garcia de Fragas, Ismail Gbadamosi et al. · 2025 · Journal of Neurochemistry
  39. Lipid and lipoprotein metabolism in microglia: Alzheimer’s disease mechanisms and interventions
    Kayla G. Sprenger, Emma E Lietzke, John Melchior, Kimberley D. Bruce · 2025 · Journal of Lipid Research
  40. Toward a New Concept of Alzheimer’s Disease Models: A Perspective from Neuroinflammation
    Antonia Gutiérrez, Javier Vitórica · 2018 · Journal of Alzheimer s Disease
  41. Intracellular accumulation of amyloid-ß is a marker of selective neuronal vulnerability in Alzheimer’s disease
    Alessia Caramello, Nurun Nahar Fancy, Clotilde Tournerie, Maxine Eklund, Vicky M. N. Chau, Emily Adair, Marianna Papageorgopoulou, Nanet Willumsen, Johanna Jackson, John Hardy et al. · 2025 · Nature Communications
  42. G-CSF drives autoinflammation in APLAID
    Elisabeth Mulazzani, Klara Kong, Juan I. Aróstegui, Ashley P. Ng, Nishika Ranathunga, Waruni Abeysekera, Alexandra L. Garnham, Sze‐Ling Ng, Paul J. Baker, Jacob T. Jackson et al. · 2023 · Nature Immunology
  43. Neuroprotective Effects of Amylin Analogues on Alzheimer’s Disease Pathogenesis and Cognition
    John Grizzanti, Rachel R. Corrigan, Gemma Casadesús · 2018 · Journal of Alzheimer s Disease
  44. Microglia in Alzheimer’s Disease
    Patrick Süß, Johannes C. M. Schlachetzki · 2020 · Current Alzheimer Research
  45. Neuroinflammation across the Spectrum of Neurodegenerative Diseases: Mechanisms and Therapeutic Frontiers
    Karyme M. Alemán-Villa, David A. Armienta-Rojas, Josué Camberos-Barraza, Ángel Radamés Rábago-Monzón, Alejandro Camacho-Zamora, Juan Fidel Osuna‐Ramos, Javier A. Magaña‐Gómez, Alma Marlene Guadrón‐Llanos, Loranda Calderón-Zamora, Claudia Desireé Norzagaray-Valenzuela et al. · 2025 · NeuroImmunoModulation
  46. Tau-Mediated Dysregulation of Neuroplasticity and Glial Plasticity
    Emily J. Koller, Paramita Chakrabarty · 2020 · Frontiers in Molecular Neuroscience
  47. Microglia-specific regulation of lipid metabolism in Alzheimer’s disease revealed by microglial depletion in 5xFAD Mice
    Ziying Xu, Sepideh Kiani Shabestari, Savannah Barannikov, Kevin F. Bieniek, Mathew M. Blurton-Jones, Juan Pablo Palavicini, Xianlin Han · 2025 · Nature Communications
  48. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer’s disease
    H. Marei, Muhammad Umar Aslam Khan, Anwarul Hasan · 2023 · Cellular & Molecular Biology Letters
  49. TREM2 in Neurodegenerative Disorders: Mutation Spectrum, Pathophysiology, and Therapeutic Targeting
    Hye-Won Yang, Danyeong Kim, YoungSoon Yang, Eva Bagyinszky, Seong Soo A. An · 2025 · International Journal of Molecular Sciences
  50. DNA methylation and stroke prognosis: an epigenome-wide association study
    2024
  51. Leveraging gene co-regulation to identify gene sets enriched for disease heritability
    Katherine M. Siewert, Samuel Sungil Kim, Douglas W. Yao, Huwenbo Shi, Alkes L. Price · 2022 · The American Journal of Human Genetics
  52. Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer’s disease
    Farid Rajabli, Penelope H. Benchek, Giuseppe Tosto, Nicholas A. Kushch, Jin Sha, Katrina Bazemore, Congcong Zhu, Wan‐Ping Lee, Jacob Haut, Kara L. Hamilton‐Nelson et al. · 2025 · Genome biology
  53. LSMM: a statistical approach to integrating functional annotations with genome-wide association studies
    Jingsi Ming, Mingwei Dai, Mingxuan Cai, Xiang Wan, Jin Liu, Can Yang · 2018 · Bioinformatics
  54. An APOE -independent cis -eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk
    Shuquan Rao, Mahdi Ghani, Zhiyun Guo, Yuetiva K. Deming, Kesheng Wang, Rebecca Sims, Canquan Mao, Yao Yao, Carlos Cruchaga, Dietrich A. Stephan et al. · 2018 · Neurobiology of Aging
  55. Glucocerebrosidase mutations: A paradigm for neurodegeneration pathways
    Sophia R.L. Vieira, Anthony H.V. Schapira · 2021 · Free Radical Biology and Medicine
  56. Bidirectional crosstalk between microglia and serotonin signaling in neuroinflammation and CNS disorders
    Yangchen Zheng, Limin Xu · 2025 · Frontiers in Immunology
  57. Heterozygous expression of the Alzheimer’s disease-protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapses
    Solomon, Shiden, Sampathkumar, Nirmal Kumar, Carre, Ivo, Mondal, Mrityunjoy, Chennell, George, Vernon, Anthony C., Ruepp, Marc-David, Mitchell, Jacqueline C · 2022 · Cellular and Molecular Life Sciences
  58. Selective neuronal vulnerability in Alzheimer's disease.
    Zuo-Teng Wang, Can Zhang, Yan-Jiang Wang, Q. Dong, L. Tan, Jin-Tai Yu · 2020 · Ageing Research Reviews
  59. Meta-Analysis of the Association between Variants in ABCA7 and Alzheimer’s Disease
    Fang-Chen Ma, Hui-Fu Wang, Xi‐Peng Cao, Chen‐Chen Tan, Lan Tan, Jin‐Tai Yu · 2018 · Journal of Alzheimer s Disease
  60. Immunotherapy for neurodegeneration?
    Yingjun Liu, Adriano Aguzzi · 2019 · Science
  61. The effect of Abi3 locus deletion on the progression of Alzheimer’s disease-related pathologies
    Karahan, Hande, Smith, Daniel C., Kim, Byungwook, McCord, Brianne, Mantor, Jordan, John, Sutha K., Al-Amin, Md Mamun, Dabin, Luke C., Kim, Jungsu · 2023 · Frontiers in Immunology
  62. APOEε4 and risk of Alzheimer’s disease – time to move forward
    Iliya M. Lefterov, Nicholas Francis Fitz, Yi Lü, Radosveta P. Koldamova · 2023 · Frontiers in Neuroscience
  63. Mutation analysis of disease causing genes in patients with early onset or familial forms of Alzheimer’s disease and frontotemporal dementia
    María Pagnon de la Vega, Carl Näslund, RoseMarie Brundin, Lars Lannfelt, Malin Löwenmark, Lena Kilander, Martin Ingelsson, Vilmantas Giedraitis · 2022 · BMC Genomics
  64. Shared Biological Pathways Between Alzheimer’s Disease and Ischemic Stroke
    Pan Cui, Xiaofeng Ma, He Li, Wenjing Lang, Junwei Hao · 2018 · Frontiers in Neuroscience
  65. Pathways linking Alzheimer’s disease risk genes expressed highly in microglia
    Hodges, Angela K., Piers, Thomas M., Collier, David, Cousins, Oliver, Pocock, Jennifer M. · 2021 · Neuroimmunology and Neuroinflammation
  66. Transcriptional profiling in microglia across physiological and pathological states identifies a transcriptional module associated with neurodegeneration
    Ayşegül Güvenek, Neelroop Parikshak, Daria Zamolodchikov, Sahar Gelfman, Arden Moscati, Lee Dobbyn, Eli A. Stahl, Alan R. Shuldiner, Giovanni Coppola · 2024 · Communications Biology
  67. Altered Bile Acid Profile Associates with Cognitive Impairment in Alzheimer’s Disease – An Emerging Role for Gut Microbiome
    2018
  68. Vascular Dysfunction in Alzheimer’s Disease: Alterations in the Plasma Contact and Fibrinolytic Systems
    Ana Badimon, Daniel Torrente, Erin H. Norris · 2023 · International Journal of Molecular Sciences
  69. Exploring microglia and their phenomenal concatenation of stress responses in neurodegenerative disorders
    Thankavelu Asveda, Priti Talwar, Palaniyandi Ravanan · 2023 · Life Sciences
  70. Associations of plasma soluble CD22 levels with brain amyloid burden and cognitive decline in Alzheimer’s disease
    Xian‐Le Bu, Pu‐Yang Sun, Dong‐Yu Fan, Jun Wang, Hao‐Lun Sun, Yuan Cheng, Gui‐Hua Zeng, Dong‐Wan Chen, Huiyun Li, Xu Yi et al. · 2022 · Science Advances
  71. Molecular Insights into Cell Type-specific Roles in Alzheimer’s Disease: Human Induced Pluripotent Stem Cell-based Disease Modelling
    Wenhui Qu, Peter Canoll, Gunnar Hargus · 2022 · Neuroscience
  72. Alzheimer’s Disease Genetics: A Dampened Microglial Response?
    Zena K. Chatila, Elizabeth M. Bradshaw · 2021 · The Neuroscientist
  73. Genetic profiles of familial late-onset Alzheimer's disease in China: The Shanghai FLOAD study
    Xinyi Xie, Qianhua Zhao, Qiang Huang, Eric B. Dammer, Shengdi Chen, Ru‐Jing Ren, Gang Wang · 2021 · Genes & Diseases
  74. Characterization of the membrane interactions of phospholipase Cγ reveals key features of the active enzyme
    Le Huray, Kyle I. P., Bunney, Tom D., Pinotsis, Nikos, Kalli, Antreas C., Katan, Matilda · 2022 · Science Advances
  75. Genetics of Alzheimer Disease
    Suman Jayadev · 2022 · CONTINUUM Lifelong Learning in Neurology
  76. Influence of ADAM10 Polymorphisms on Plasma Level of Soluble Receptor for Advanced Glycation End Products and The Association With Alzheimer’s Disease Risk
    Wenhui Huang, Wei Chen, Lianying Jiang, Yixia Yang, Lifen Yao, Keshen Li · 2018 · Frontiers in Genetics
  77. Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer’s Disease
    Amy R. Nelson · 2022 · Frontiers in Aging Neuroscience
  78. Brain resident microglia in Alzheimer’s disease: foe or friends
    Simranjit Kaur, K. Malleshwari, Anamika Sharma, Vijayasree Vayalanellore Giridharan, Manoj P. Dandekar · 2024 · Inflammopharmacology
  79. Exome sequencing in an Italian family with Alzheimer’s disease points to a role for seizure-related gene 6 (SEZ6) rare variant R615H
    Lara Paracchini, Luca Beltrame, Lucia Boeri, Federica Fusco, Paolo Caffarra, Sergio Marchini, Diego Albani, Gianluigi Forloni · 2018 · Alzheimer s Research & Therapy
  80. Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective
    Isidró Ferrer · 2022 · Free Neuropathology
  81. Selection and structural characterization of anti-TREM2 scFvs that reduce levels of shed ectodomain
    Aleksandra Szykowska, Yu Chen, Thomas B. Smith, Charlotta Preger, Jingjing Yang, Dongming Qian, Shubhashish M. M. Mukhopadhyay, Edvard Wigren, Stephen J. Neame, S. Gräslund et al. · 2021 · Structure
  82. The versatile role of TREM2 in regulating of microglia fate in the ischemic stroke
    Wen-yu Ma, Shasha Wang, Qing-lin Wu, Xin‐Fu Zhou, Shifeng Chu, Nai‐Hong Chen · 2022 · International Immunopharmacology
  83. The Role of the Gut Microbiota and Microbial Metabolites in the Pathogenesis of Alzheimer’s Disease
    Yi Wang · 2022 · CNS & Neurological Disorders - Drug Targets
  84. Functional co-activation of the default mode network in APOE ε4-carriers: A replication study
    Lara J. Mentink, Joao Guimaraes, Myrthe Faber, Emma Sprooten, Marcel G. M. Olde Rikkert, Koen V. Haak, Christian F. Beckmann · 2021 · NeuroImage
  85. Diacylglycerols as biomarkers of sustained immune activation in Proteinopathies associated with dementia
    Paul L. Wood, John E. Cebak, Randall L. Woltjer · 2017 · Clinica Chimica Acta
  86. Advances in Genetic and Molecular Understanding of Alzheimer’s Disease
    Laura Ibáñez, Carlos Cruchaga, María Victoria Fernández · 2021 · Genes
  87. Cryptic mutations of PLC family members in brain disorders: recent discoveries and a deep-learning-based approach
    Lim, Key-Hwan, Yang, Sumin, Kim, Sung-Hyun, Ko, Euiseong, Kang, Mingon, Joo, Jae-Yeol · 2023 · Brain
  88. Identification of target genes in neuroinflammation and neurodegeneration after traumatic brain injury in rats
    Jianwei Zhao, Chen Xu, Heli Cao, Lin Zhang, Xuyang Wang, Shiwen Chen · 2019 · PeerJ
  89. Alzheimer's disease‐induced phagocytic microglia express a specific profile of coding and non‐coding RNAs
    Flavia Scoyni, Luca Giudice, Mari‐Anna Väänänen, Nicholas L. Downes, Paula Korhonen, Xin Yi Choo, Nelli‐Noora Välimäki, Petri I. Mäkinen, Nea Korvenlaita, Annemieke J.M. Rozemüller et al. · 2023 · Alzheimer s & Dementia
  90. Mitophagy and long-term neuronal homeostasis
    Maria Markaki, Dikaia Tsagkari, Nektarios Tavernarakis · 2023 · Journal of Cell Science
  91. Dynamics of allosteric regulation of the phospholipase C-γ isozymes upon recruitment to membranes
    Siraliev-Perez, Edhriz, Stariha, Jordan TB, Hoffmann, Reece M, Temple, Brenda RS, Zhang, Qisheng, Hajicek, Nicole, Jenkins, Meredith L, Burke, John E, Sondek, John · 2022 · eLife
  92. The Genetic Relevance of Human Induced Pluripotent Stem Cell-Derived Microglia to Alzheimer’s Disease and Major Neuropsychiatric Disorders
    Robert R. Butler, Alena Kozlova, Hanwen Zhang, Siwei Zhang, Michael Streit, Alan R. Sanders, Krzysztof Laudański, Zhiping P. Pang, Pablo V. Gejman, Jubao Duan · 2019 · Complex Psychiatry
  93. Analysis of pleiotropic genetic effects on cognitive impairment, systemic inflammation, and plasma lipids in the Health and Retirement Study
    Michael William Lutz, Ramon Casanova, Santiago J. Saldana, Maragatha N. Kuchibhatla, Brenda L. Plassman, Kathleen M. Hayden · 2019 · Neurobiology of Aging
  94. Targeting Progranulin as an Immuno-Neurology Therapeutic Approach
    Maria A. Boylan, Andrew Pincetic, Gary J. Romano, Nadine A. Tatton, Sara Kenkare-Mitra, Arnon Rosenthal · 2023 · International Journal of Molecular Sciences
  95. Association of ABI3 and PLCG2 Missense Variants With Disease Risk and Neuropathology in Lewy Body Disease and Progressive Supranuclear Palsy
    Strickland, Samantha L., Morel, Hélène, Prusinski, Christian, Allen, Mariet, Patel, Tulsi A., Carrasquillo, Minerva M., Conway, Olivia J., Lincoln, Sarah J., Reddy, Joseph S., Nguyen, Thuy et al. · 2020 · Acta Neuropathologica Communications
  96. Established and emerging techniques for the study of microglia: visualization, depletion, and fate mapping
    Bianca Caroline Bobotis, Torin Halvorson, Micaël Carrier, Marie‐Ève Tremblay · 2024 · Frontiers in Cellular Neuroscience
  97. TREM2 variants that cause early dementia and increase Alzheimer’s disease risk affect gene splicing
    Kostantin Kiianitsa, Maria E Lukes, Brian J. Hayes, Julianna N. Brutman, Paul N. Valdmanis, Thomas D. Bird, Wendy H. Raskind, Olena Korvatska · 2024 · Brain
  98. TREM2 bridges microglia and extracellular microenvironment: Mechanistic landscape and therapeutical prospects on Alzheimer’s disease
    Yiheng Zhao, Qian Guo, Jia Tian, Wei Liu, Xiaochuan Wang · 2024 · Ageing Research Reviews
  99. Defective Lysosomal Lipid Catabolism as a Common Pathogenic Mechanism for Dementia
    J. Y. Lee, Oana C. Marian, A. Don · 2021 · Neuromolecular medicine
  100. Allogenic microglia replacement: A novel therapeutic strategy for neurological disorders
    Yanxia Rao, Bo Peng · 2023 · Fundamental Research